Patrick Lefèbvre

10.5k total citations · 2 hit papers
469 papers, 7.3k citations indexed

About

Patrick Lefèbvre is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Psychiatry and Mental health. According to data from OpenAlex, Patrick Lefèbvre has authored 469 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Cardiology and Cardiovascular Medicine, 88 papers in Pulmonary and Respiratory Medicine and 73 papers in Psychiatry and Mental health. Recurrent topics in Patrick Lefèbvre's work include Atrial Fibrillation Management and Outcomes (63 papers), Venous Thromboembolism Diagnosis and Management (51 papers) and Health Systems, Economic Evaluations, Quality of Life (50 papers). Patrick Lefèbvre is often cited by papers focused on Atrial Fibrillation Management and Outcomes (63 papers), Venous Thromboembolism Diagnosis and Management (51 papers) and Health Systems, Economic Evaluations, Quality of Life (50 papers). Patrick Lefèbvre collaborates with scholars based in United States, Canada and France. Patrick Lefèbvre's co-authors include Mei Sheng Duh, Dominic Pilon, Marie‐Hélène Lafeuille, François Laliberté, Kruti Joshi, Jeff Schein, Bruno Émond, Winnie W. Nelson, Brahim Bookhart and Maryia Zhdanava and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Patrick Lefèbvre

447 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States

2021 296 citations Maryia Zhdanava, Dominic Pilon et al. profile →
The Economic Burden of Posttraumatic Stress Disorder in the United States From a Societal Perspective

2022 108 citations Jeff Schein, Martin Cloutier et al. profile →

Peers

Countries citing papers authored by Patrick Lefèbvre

Since Specialization

Citations

This map shows the geographic impact of Patrick Lefèbvre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Lefèbvre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Lefèbvre more than expected).

Fields of papers citing papers by Patrick Lefèbvre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Lefèbvre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Lefèbvre. The network helps show where Patrick Lefèbvre may publish in the future.

Co-authorship network of co-authors of Patrick Lefèbvre

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Lefèbvre. A scholar is included among the top collaborators of Patrick Lefèbvre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Lefèbvre. Patrick Lefèbvre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States 2024 ·Journal of Medical Economics ·Deborah R. Kaye, (unknown), Erik Muser, Laura Morrison, (unknown), Patrick Lefèbvre, Dominic Pilon, Daniel J. George	2
2	Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA 2023 ·Dermatology and Therapy ·Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Aditi Shah, (unknown), Patrick Lefèbvre, Steven R. Feldman	13
3	Respiratory Syncytial Virus–Related Complications and Healthcare Costs Among a Medicare-Insured Population in the United States 2023 ·Open Forum Infectious Diseases ·Jessica K. DeMartino, Marie‐Hélène Lafeuille, Bruno Émond, Carmine Rossi, Jingru Wang, (unknown), Patrick Lefèbvre, Girishanthy Krishnarajah	7
4	43312 Long term psoriasis control with guselkumab versus secukinumab and ixekizumab among bio- experienced patients: analysis of drug persistence in large claims database 2023 ·Journal of the American Academy of Dermatology ·Maryia Zhdanava, Timothy Fitzgerald, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, (unknown), Patrick Lefèbvre, Steven R. Feldman	1
5	Real-world clinical management of individuals with Rett syndrome: a physician survey 2023 ·Journal of Medical Economics ·(unknown), Jeffrey L. Neul, Ambika Satija, Wendy Y. Cheng, (unknown), (unknown), Patrick Lefèbvre, J. Eric Piña-Garza	2
6	43038 Long term psoriasis control with guselkumab versus secukinumab and ixekizumab among bio- naïve patients: analysis of drug persistence in large claims database 2023 ·Journal of the American Academy of Dermatology ·Timothy Fitzgerald, Maryia Zhdanava, Dominic Pilon, Rachel E. Teneralli, Aditi Shah, (unknown), Patrick Lefèbvre, Steven R. Feldman	1
7	Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH) 2023 ·PharmacoEconomics - Open ·Hilary M. DuBrock, Hayley D. Germack, Marjolaine Gauthier‐Loiselle, (unknown), Ambika Satija, Ameur M. Manceur, Martin Cloutier, Patrick Lefèbvre, Sumeet Panjabi, Robert P. Frantz	3
8	Real-World Comparison of First-Line Treatment Adherence Between Single-Agent Ibrutinib and Acalabrutinib in Patients with Chronic Lymphocytic Leukemia 2023 ·Patient Preference and Adherence ·Xiaoxiao Lu, Bruno Émond, Laura Morrison, (unknown), Patrick Lefèbvre, Marie‐Hélène Lafeuille, (unknown), Linda Wu, Zaina P. Qureshi, Ryan Jacobs	3
9	Real-world time to discontinuation of first-line venetoclax + obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma 2023 ·Current Medical Research and Opinion ·Xiaoxiao Lu, Bruno Émond, Zaina P. Qureshi, Linda Wu, (unknown), (unknown), (unknown), Marie‐Hélène Lafeuille, Patrick Lefèbvre, Qing Huang, Kerry A. Rogers	1
10	Real-World Persistence and Time to Next Treatment With Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Including Patients at High Risk for Atrial Fibrillation or Stroke 2022 ·Clinical Lymphoma Myeloma & Leukemia ·Anna Narezkina, Nausheen Akhter, Xiaoxiao Lu, Bruno Émond, Sumeet Panjabi, (unknown), (unknown), (unknown), Marie‐Hélène Lafeuille, Patrick Lefèbvre, Qing Huang, Michael Y. Choi	10
11	The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients 2022 ·Diabetes & Metabolism ·Benjamin Rivière, Audrey Jaussent, Valérie Macioce, Stéphanie Faure, Nicolas Builles, Patrick Lefèbvre, (unknown), Marie‐Christine Picot, Sandra A. Rebuffat, Éric Renard, Valérie Paradis, (unknown), Nathalie de Préville, David Nocca, Anne‐Dominique Lajoix, Georges‐Philippe Pageaux, Florence Galtier	29
12	Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab 2022 ·Current Medical Research and Opinion ·(unknown), Richard Melsheimer, Rachel H. Bhak, Patrick Lefèbvre, Maral DerSarkissian, Bruno Émond, (unknown), Catherine Nguyen, Melody Wu, Yinong Young‐Xu	5
13	Comparative Effectiveness and Safety of Rivaroxaban and Warfarin Among Nonvalvular Atrial Fibrillation (NVAF) Patients with Obesity and Polypharmacy in the United States (US) 2021 ·Advances in Therapy ·Jeffrey S. Berger, François Laliberté, (unknown), Dominique Lejeune, Kenneth Todd Moore, Young Yun Jung, Patrick Lefèbvre, Veronica Ashton	5
14	Development of predictive risk models for major adverse cardiovascular events among patients with type 2 diabetes mellitus using health insurance claims data 2018 ·Cardiovascular Diabetology ·James B. Young, Marjolaine Gauthier‐Loiselle, Robert A. Bailey, Ameur M. Manceur, Patrick Lefèbvre, Morris Greenberg, Marie‐Hélène Lafeuille, Mei Sheng Duh, Brahim Bookhart, Carol Wysham	31
15	Out‐of‐pocket medical costs and third‐party healthcare costs for children with Down syndrome 2016 ·American Journal of Medical Genetics Part A ·Andrew Kageleiry, (unknown), Mei Sheng Duh, Patrick Lefèbvre, John Campbell, Brian G. Skotko	22
16	Abstract 13611: Adherence to Non-VKA Oral Anticoagulant Medications Based on the Pharmacy Quality Alliance Measure 2015 ·Circulation ·Colleen A. McHorney, Concetta Crivera, François Laliberté, Winnie W. Nelson, (unknown), Brahim Bookhart, (unknown), Jeffrey Schein, Patrick Lefèbvre, Steven Deitelzweig	1
17	Abstract 9213: Risk of Gastrointestinal Conditions Among Patients with Atrial Fibrillation 2011 ·Circulation ·François Laliberté, (unknown), Katherine Dea, Joyce LaMori, Samir H. Mody, (unknown), (unknown), (unknown), (unknown), Jeff Schein, Patrick Lefèbvre	0
18	Generic antiepileptic drugs and associated medical resource utilization in the United States 2010 ·Neurology ·David M. Labiner, Pierre Emmanuel Paradis, R Manjunath, Mei Sheng Duh, (unknown), Dominick Latrémouille-Viau, Patrick Lefèbvre, S. L. Helmers	53
19	Traitement du diabète de type II insulino-requérant: intérêt potentiel de l'association insuline-antidiabétiques oraux 1996 ·Open Repository and Bibliography (University of Liège) ·André Scheen, Nicolas Paquot, M. Castillo, Patrick Lefèbvre	0
20	Les cures de jeûne modifié, protidique ou glucido-protidique, dans le traitement de l'obésité morbide. 1988 ·Open Repository and Bibliography (University of Liège) ·André Scheen, (unknown), (unknown), Bernard Jandrain, Nicolas Paquot, Patrick Lefèbvre	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact